Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
100.49
+6.69 (7.13%)
At close: Dec 5, 2025, 4:00 PM EST
102.49
+2.00 (1.99%)
After-hours: Dec 5, 2025, 5:49 PM EST
Palvella Therapeutics Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Palvella Therapeutics stock have an average target of 124.25, with a low estimate of 38 and a high estimate of 200. The average target predicts an increase of 23.64% from the current stock price of 100.49.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Palvella Therapeutics stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 8 | 9 | 12 |
| Buy | 1 | 3 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 11 | 12 | 12 | 13 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Clear Street | Clear Street | Strong Buy Initiates $200 | Strong Buy | Initiates | $200 | +99.02% | Dec 5, 2025 |
| BTIG | BTIG | Strong Buy Initiates $167 | Strong Buy | Initiates | $167 | +66.19% | Dec 5, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $175 | Strong Buy | Initiates | $175 | +74.15% | Dec 4, 2025 |
| Stifel | Stifel | Strong Buy Maintains $87 → $145 | Strong Buy | Maintains | $87 → $145 | +44.29% | Nov 24, 2025 |
| Raymond James | Raymond James | Buy → Strong Buy Upgrades $92 → $143 | Buy → Strong Buy | Upgrades | $92 → $143 | +42.30% | Nov 19, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
40.80K
EPS This Year
-3.56
from -7.83
EPS Next Year
-3.91
from -3.56
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | 420,000 | ||||
| Avg | n/a | 40,800 | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.98 | -2.99 | ||||
| Avg | -3.56 | -3.91 | ||||
| Low | -3.57 | -4.82 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.